|

Zoldonrasib Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Revolution Medicines, Inc.1

Indications

  • Metastatic Solid Tumors1
  • CRC1
  • Non-small Cell Lung Cancer (NSCLC)1
  • Colorectal Cancer (CRC)1
  • Advanced Solid Tumors1

Fairfax, Virginia1 trial

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

NEXT Virginia

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.